The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism. - Wikidata - wikimedia - TriplyDB

The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.

The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.

http://www.wikidata.org/entity/Q34395516

about

Neuroprotective effect of Danshensu derivatives as anti-ischaemia agents on SH-SY5Y cells and rat brain Hemoglobin-Improved Protection in Cultured Cerebral Cortical Astroglial Cells: Inhibition of Oxidative Stress and Caspase Activation.Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders.Neuroglobin protects astroglial cells from hydrogen peroxide-induced oxidative stress and apoptotic cell death.The stimulatory effect of the octadecaneuropeptide ODN on astroglial antioxidant enzyme systems is mediated through a GPCR.Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.Endogenous Expression of ODN-Related Peptides in Astrocytes Contributes to Cell Protection Against Oxidative Stress: Astrocyte-Neuron Crosstalk Relevance for Neuronal Survival.Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate/protein kinase A pathway.The octadecaneuropeptide ODN prevents 6-hydroxydopamine-induced apoptosis of cerebellar granule neurons through a PKC-MAPK-dependent pathway.Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.Investigations of octylglyceryl dextran-graft-poly(lactic acid) nanoparticles for peptide delivery to the brain.Prenatal exposure to cigarette smoke enhances oxidative stress in astrocytes of neonatal rat.

P2860

Q37137684-B68CE4D6-545B-4049-9363-8496D1F80C06 Q38819908-5409569F-7645-4B73-9F22-BE9F5CD40E89 Q39181656-C54A8BD5-CAAC-48CB-A353-A4C5C930D9C7 Q39243872-37A343B3-7DCB-4A19-A449-541A8317B319 Q41635046-1C5C3558-C867-43CF-AAE0-1CB73A225024 Q44448576-B835975F-6484-4555-8DBA-20AB02BB13AC Q46306392-5DC46067-21F1-4A04-BF3A-E07067C424B5 Q46493701-29BF372C-02A2-48CA-9578-2F315403B000 Q46806237-1E3A127D-CB7E-4791-AD4D-B6F0621644D2 Q47267653-529B1130-6F1E-4252-910F-3321F152345B Q48247082-3FEB54FB-B57D-41F9-9BBB-11E5472704EA Q48821556-D5D259E9-D6E6-43FD-BD22-BF0F3E9FFC36

P2860

The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.

http://www.wikidata.org/entity/Q34395516

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@ast

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@en

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@nl

type

label

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@ast

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@en

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@nl

prefLabel

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@ast

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@en

The octadecaneuropeptide ODN p ...... PKA/MAPK-dependent mechanism.

@nl

P1433

Q34395516-65119F9D-5D97-4CD1-AFC4-1C92B1C29A21

P1476

Q34395516-B5D28F60-5FCE-45B9-A4B7-E31B121CE9F7

P2093

Q34395516-02D63677-DADD-4D1A-8BB7-F5ABC3553E47

Q34395516-31ADD567-D797-4197-9DFA-AFF8FB7D4018

Q34395516-3748FB26-B504-4021-8EEC-330DFACD7032

Q34395516-67102E40-1201-4B48-A458-57BF085E55BD

Q34395516-6ADFB9F1-1A96-4FD7-9AB9-C22936100059

Q34395516-72489C92-0A21-41C5-96C2-0CD87C1D7BF7

Q34395516-826829F2-22A1-490B-BEF1-056975B51179

Q34395516-9062C799-4F07-42EF-A601-8D557CCB0F94

Q34395516-9AB54EC7-FD39-46DF-8214-D8A86A79087E

Q34395516-F189CF2C-EC0C-4133-A03E-BA2597E6DFD0

P2860

Q34395516-06E4DD7E-695A-45D7-9CA1-34221687E98A

Q34395516-0CA10529-72AC-436F-B3B1-A8BA4785AF61

Q34395516-0CBC5D66-BB93-4FCD-AA5B-C625A5533F08

Q34395516-0CEB61C5-CD52-41AF-B4A0-8FF8BE257D94

Q34395516-0F99131D-C5D7-43CE-A8B5-18639440789F

Q34395516-10602C11-586C-48E6-9ABE-BAEC8BC6FDC3

Q34395516-17F52682-9647-4758-907A-500D63C20CF4

Q34395516-1AA2560F-CC6F-472A-B01E-6B168F98D626

Q34395516-1AAFF7F6-FC38-4A67-98B8-00490388FF50

Q34395516-1BA6114B-4C09-4FE1-AD47-817681ACA1C0

P304

Q34395516-4A0D74DE-ED92-4D49-8732-6AE0F4B98B46

P31

Q34395516-67A84B0B-09DC-43D4-9F25-C08D09150358

P356

Q34395516-BA69DE83-BC46-4137-BA13-064C879BEC6B

P407

Q34395516-11513412-3191-4B5D-A699-333724A1C057

P433

Q34395516-69F24DAD-BDE6-45A5-99F1-40FFC2777653

P478

Q34395516-94896902-1092-4E24-A6FE-70B9F4939960

P50

Q34395516-B5EE9D29-2A8F-456F-ABF1-ACB762597124

P577

Q34395516-5801DF22-6485-4809-A05B-16230BCE5242

P5875

Q34395516-65E5B1A0-32CF-49EA-A9D2-0AA8D726AF64

P698

Q34395516-9D814056-09F2-431A-9535-290A4ABC4258

P921

Q34395516-7a2c38ed-b5f3-4650-82d6-9adc76a6d3c0

P932

Q34395516-6B858228-9F74-459F-94BA-E86647E38DA8

P356

JOURNAL.PONE.0042498

P1433

P1476

The octadecaneuropeptide ODN p ...... a PKA/MAPK-dependent mechanism

@en

P2093

David Vaudry

http://www.w3.org/2001/XMLSchema#string

Hadhemi Kaddour

http://www.w3.org/2001/XMLSchema#string

Helene Castel

http://www.w3.org/2001/XMLSchema#string

Hubert Vaudry

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Tonon

http://www.w3.org/2001/XMLSchema#string

Mohamed Amri

http://www.w3.org/2001/XMLSchema#string

Olfa Masmoudi-Kouki

http://www.w3.org/2001/XMLSchema#string

Salma Douiri

http://www.w3.org/2001/XMLSchema#string

Seyma Bahdoudi

http://www.w3.org/2001/XMLSchema#string

Yosra Hamdi

http://www.w3.org/2001/XMLSchema#string

P2860

Evolution of the acyl-CoA binding protein (ACBP)

Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes

Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors

Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes

Beta-amyloid peptide stimulates endozepine release in cultured rat astrocytes through activation of N-formyl peptide receptors

Ontogeny of diazepam binding inhibitor/acyl-CoA binding protein mRNA and peripheral benzodiazepine receptor mRNA expression in the rat

Death signaling pathway induced by pyrrolidine dithiocarbamate-Cu(2+) complex in the cultured rat cortical astrocytes.

The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents.

Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain.

Protective effects of the free radical scavenger edaravone against glutamate neurotoxicity in nearly pure neuronal culture.

P304

e42498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0042498

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Jérôme Leprince

P577

2012-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230749373

http://www.w3.org/2001/XMLSchema#string

P698

22927932

http://www.w3.org/2001/XMLSchema#string

P921

P932

3424241

http://www.w3.org/2001/XMLSchema#string